Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takatomo Arai

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|September 23, 2018
HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liverTakatomo Arai, Masako Tanaka, Nobuhito Goda
The International Journal of Neuropsychopharmacology|July 26, 2022
5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X SyndromeMayako Yamazaki, Takatomo Arai, Junko Yarimizu, et al.
World Journal of Gastroenterology|November 12, 2014
Hypoxia and fatty liverTomohiro Suzuki, Satoko Shinjo, Takatomo Arai, et al.
Hepatology Communications|May 16, 2018
Loss of hypoxia inducible factor-1α aggravates γδ T-cell-mediated inflammation during acetaminophen-induced liver injuryTomohiro Suzuki, Shoko Minagawa, Takashi Yamazaki, et al.
Scientific Reports|February 21, 2017
Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in miceTakatomo Arai, Yumika Ono, Yujiro Arimura, et al.
Journal of Hepatology|February 15, 2015
WITHDRAWN: Loss of hepatic HIF-1α accelerates lipid accumulation by inhibiting peroxisomal fatty acid oxidation in nonalcoholic fatty liver diseaseTakatomo Arai, Yuki Kato, Kenji Ishimoto, et al.
Nature Communications|March 14, 2025
Liver-derived Neuregulin1α stimulates compensatory pancreatic β cell hyperplasia in insulin resistanceTakatomo Arai, Eriko Hayashi, Sumie Maeda, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|September 23, 2018
HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liverTakatomo Arai, Masako Tanaka, Nobuhito Goda
The International Journal of Neuropsychopharmacology|July 26, 2022
5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X SyndromeMayako Yamazaki, Takatomo Arai, Junko Yarimizu, et al.
World Journal of Gastroenterology|November 12, 2014
Hypoxia and fatty liverTomohiro Suzuki, Satoko Shinjo, Takatomo Arai, et al.
Hepatology Communications|May 16, 2018
Loss of hypoxia inducible factor-1α aggravates γδ T-cell-mediated inflammation during acetaminophen-induced liver injuryTomohiro Suzuki, Shoko Minagawa, Takashi Yamazaki, et al.
Scientific Reports|February 21, 2017
Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in miceTakatomo Arai, Yumika Ono, Yujiro Arimura, et al.
Journal of Hepatology|February 15, 2015
WITHDRAWN: Loss of hepatic HIF-1α accelerates lipid accumulation by inhibiting peroxisomal fatty acid oxidation in nonalcoholic fatty liver diseaseTakatomo Arai, Yuki Kato, Kenji Ishimoto, et al.
Nature Communications|March 14, 2025
Liver-derived Neuregulin1α stimulates compensatory pancreatic β cell hyperplasia in insulin resistanceTakatomo Arai, Eriko Hayashi, Sumie Maeda, et al.
Pageof 1